Utility of a Modified Calibration Model for Reliable Conversion of Thromboplastin Times to International Normalized Ratios

Summary

The combined thromboplastin reagent, Normotest, has been calibrated against the secondary international reference preparation for bovine thromboplastin, OBT/79. Three expert laboratories measured up to 62 patients on stabilized oral anticoagulant therapy and up to 20 normals in order to establish an INR-scale for Normotest. It was found that the model recommended by the WHO was less suited for the calibration of this thromboplastin. This is the first study in which three independent laboratories demonstrate a similar bias of the WHO calibration model. A modified model in which a correction factor is introduced was applied to the problem and proved to give a reliable calculation method for INR on Normotest. The mean coefficient of variation of INR calculated between measurements with Normotest and OBT/79 (scatter of data around calibration line) was 4.2-5.0% as compared to 5.1-5.7% for the WHO-method. A conversion scale for percent activities between Normotest and Thrombotest was established showing that the recommended therapeutic range of 5-10% Thrombotest (INR = 4.8-2.8) corresponds to 10-20% Normotest.

Key words

Thromboplastin calibration - INR - Normotest

• References

• 1 WHO Expert Committee on Biological Standardization. 33rd Report. WHO Technical Report Series 1983; 687: 81-105
• 2 Kirkwood TB L. Calibration of reference thromboplastins and standardization of the prothrombin time ratio. Thromb Haemostas 1983; 49: 238-244
• 3 Hermans J, van den Besselaar AM H P, Loeliger EA, van der Velde EA. A collaborative calibration study of reference materials for thromboplastins. Thromb Haemostas 1983; 50: 712-717
• 4 Thomson JM, Tomenson JA, Poller L. The calibration of the second primary international reference preparation for thromboplastins (thromboplastin, human, plain, coded BCT/253). Thromb Haemostas 1984; 52: 336-342
• 5 Loeliger EA, van den Besselaar AM H P, Lewis SM. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thromb Haemostas 1985; 53: 148-154
• 6 van der Velde EA. Orthogonal regression equation. In: Thromboplastin Calibration and Oral Anticoagulant Control Van den Besselaar AM H P, Gralnick HR, Lewis SM. (eds.) pp 25-39 Martinus Nijhoff: The Hague; 1984
• 7 Welch BL. The generalization of “Students” problem when several different populations variances are involved. Biometrika 1947; 34: 28
• 8 Tomenson JA. A statisticians independent evaluation. In: Thromboplastin Calibration and Oral Anticoagulant Control Van den Besselaar AM H P, Gralnick HR, Lewis SM. (eds.) pp 87-108 Martinus Nijhoff: The Hague; 1984
• 9 Loeliger EA, Poller L, Samama M, Thomson JM, van den Besselaar AM H P, Vermylen J, Verstraete M. Questions and answers on prothrombin time standardization in oral anticoagulant control. Thromb Haemostas 1985; 54: 515-517
• 10 van den Besselaar AM H P, van der Velde EA. The manufacturers calibration study. In: Thromboplastin Calibration and Oral Anticoagulant Control Van den Besselaar AM H P, Gralnick HR, Lewis SM. (eds.) pp 127-149 Martinus Nijhoff: The Hague; 1984
• 11 Refsum N, Arnesen H, Gilhuus-Moe CC, Godai HC. The relationship between Normotest and Thrombotest in patients on oral anticoagulant therapy. Scand J Haematol 1977; 18: 333-336